Maynards to manage asset dispersal at former Avonmouth pharma site

Recently the company completed the dispersal of the complete contents of Recipharm’s Ashton-under-Lyne pharmaceutical manufacturing facility

Maynards Europe is set to oversee the initial stages in a UK regeneration project following the acquisition of the 100-acre Avlon Works pharmaceutical processing site in the heart of Avonmouth Severnside by the Vancouver-based Epta Development Corporation (EDC) in December.

Maynards will manage the asset recovery and demolition of the former pharmaceutical plant. The company says it expects to put together a sales catalogue of more than 5,000 lots, to include “everything above ground”.

Once the site has been cleared, EDC plan a warehousing and logistics park comprising c.1,850,000 sqm.

The site was operational for 50 years from 1969 to 2019. In 2016 AstraZeneca sold the site to Avara Pharmaceutical in the hope of securing the operation’s future, but Avara fell into administration and the entire site was put up for sale.

“With the complete contents of the 100-acre facility for sale, Maynards is offering a unique opportunity to purchase complete pharmaceutical production lines or individual assets,” said UK Managing Director Daniel Gray. “The spares inventory alone is valued at more than £2.5 million, but add to that site support equipment, site infrastructure, offices, labs, warehouse equipment, workshops, data centres, building structures and much more, and it is easy to see just how substantial and significant this offer is.”

All the equipment has been professionally cleaned and purged, and Avara staff have been retained to assist in answering technical questions, providing data and assisting with sales and equipment removal from site. Full data sheets of the complete inventory are available to interested parties.

Among the equipment and facilities to be disposed of are five Large-Scale cGMP API Plants, with 6-10m3 reactors, pressure filter, conical and centrifuge drying, two Large-Scale Milling Facilities with Hosakawa mills and a cGMP kilo scale facility with 20-100 L reactors.

“The Avonmouth site has long been a major national distribution hub for its products, and so is perfectly situated for effective asset disposal, with additional nearby port connections,” said Gray.

Companies